FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2170830743> ?p ?o ?g. }

• W2170830743 endingPage "802" @default.
• W2170830743 startingPage "4796" @default.
• W2170830743 abstract "Tumor cell metastasis involves a complex series of interdependent events, including repeated invasion of basement membranes. Studies from several laboratories have implicated tumor cell adhesion and migration in response to laminin as a major contributing factor in tumor cell invasion. The current studies address the direct role of type IV collagen in promoting tumor cell adhesion, spreading, and migration. The observations of type IV collagen-mediated cellular behavior are contrasted with cellular behavior on type I collagen. The highly metastatic K1735 M4 melanoma cell line adhered, spread, and migrated in response to type IV collagen in a concentration-dependent manner. Functional assays using well-defined proteolytic fragments of type IV collagen demonstrated that melanoma cells interact with multiple domains of this protein. Highly metastatic melanoma cells adhered, spread, and exhibited motile behavior in response to 0.2 to 200 nM concentrations of a purified pepsin-generated, triple helix-rich domain of type IV collagen. In contrast, cells adhered and spread but were essentially nonmotile in response to a purified major noncollagenous domain of the protein. In addition, de novo protein synthesis was required for cell adhesion to the major noncollagenous domain, whereas adhesion to the helical domain was less dependent upon de novo protein synthesis. Arg-Gly-Asp (RGD)-related peptides were used to study the adhesion and spreading of melanoma cells on type IV collagen. The results demonstrated that a serine containing RGD-related peptide (GRGDSP) has virtually no effect on melanoma cell adhesion on type IV collagen-coated substrata, whereas this peptide inhibited melanoma cell adhesion to fibronectin-coated substrata in a concentration-dependent manner. In contrast, when threonine was substituted for serine (GRGDTP), cell adhesion to type IV collagen was significantly (45%) inhibited. The threonine-containing peptide virtually eliminated cell adhesion on substrata coated with type I collagen. These data demonstrate that adhesion, spreading, and migration of melanoma cells on type IV collagen have a complex molecular basis which is partially dependent on RGD-related sequences." @default.
• W2170830743 created "2016-06-24" @default.
• W2170830743 creator A5006806405 @default.
• W2170830743 creator A5036755430 @default.
• W2170830743 creator A5046609451 @default.
• W2170830743 creator A5078768906 @default.
• W2170830743 date "1989-09-01" @default.
• W2170830743 modified "2023-09-23" @default.
• W2170830743 title "Type IV collagen-mediated melanoma cell adhesion and migration: involvement of multiple, distinct domains of the collagen molecule." @default.
• W2170830743 cites W1479893041 @default.
• W2170830743 cites W1494584625 @default.
• W2170830743 cites W1520299912 @default.
• W2170830743 cites W1549624320 @default.
• W2170830743 cites W1552954655 @default.
• W2170830743 cites W1579446540 @default.
• W2170830743 cites W1593925036 @default.
• W2170830743 cites W1600335679 @default.
• W2170830743 cites W1849981627 @default.
• W2170830743 cites W1975364338 @default.
• W2170830743 cites W1987718692 @default.
• W2170830743 cites W1988965035 @default.
• W2170830743 cites W1999666756 @default.
• W2170830743 cites W2006140887 @default.
• W2170830743 cites W2020076782 @default.
• W2170830743 cites W2029591777 @default.
• W2170830743 cites W2032029508 @default.
• W2170830743 cites W2034244905 @default.
• W2170830743 cites W2056031607 @default.
• W2170830743 cites W2061752211 @default.
• W2170830743 cites W2073785437 @default.
• W2170830743 cites W2084258562 @default.
• W2170830743 cites W2085394534 @default.
• W2170830743 cites W2088074670 @default.
• W2170830743 cites W2088546959 @default.
• W2170830743 cites W2104685950 @default.
• W2170830743 cites W2115482699 @default.
• W2170830743 cites W2138539863 @default.
• W2170830743 cites W2171921813 @default.
• W2170830743 cites W2257712216 @default.
• W2170830743 cites W2299038488 @default.
• W2170830743 cites W2299663379 @default.
• W2170830743 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2758412" @default.
• W2170830743 hasPublicationYear "1989" @default.
• W2170830743 type Work @default.
• W2170830743 sameAs 2170830743 @default.
• W2170830743 citedByCount "36" @default.
• W2170830743 countsByYear W21708307432013 @default.
• W2170830743 countsByYear W21708307432015 @default.
• W2170830743 countsByYear W21708307432017 @default.
• W2170830743 countsByYear W21708307432018 @default.
• W2170830743 countsByYear W21708307432019 @default.
• W2170830743 countsByYear W21708307432020 @default.
• W2170830743 countsByYear W21708307432021 @default.
• W2170830743 countsByYear W21708307432022 @default.
• W2170830743 crossrefType "journal-article" @default.
• W2170830743 hasAuthorship W2170830743A5006806405 @default.
• W2170830743 hasAuthorship W2170830743A5036755430 @default.
• W2170830743 hasAuthorship W2170830743A5046609451 @default.
• W2170830743 hasAuthorship W2170830743A5078768906 @default.
• W2170830743 hasConcept C134018914 @default.
• W2170830743 hasConcept C1491633281 @default.
• W2170830743 hasConcept C16224149 @default.
• W2170830743 hasConcept C178790620 @default.
• W2170830743 hasConcept C185592680 @default.
• W2170830743 hasConcept C189165786 @default.
• W2170830743 hasConcept C2776193487 @default.
• W2170830743 hasConcept C2777107211 @default.
• W2170830743 hasConcept C2777658100 @default.
• W2170830743 hasConcept C2779814568 @default.
• W2170830743 hasConcept C2780644872 @default.
• W2170830743 hasConcept C502942594 @default.
• W2170830743 hasConcept C55493867 @default.
• W2170830743 hasConcept C84416704 @default.
• W2170830743 hasConcept C85789140 @default.
• W2170830743 hasConcept C86803240 @default.
• W2170830743 hasConcept C95444343 @default.
• W2170830743 hasConceptScore W2170830743C134018914 @default.
• W2170830743 hasConceptScore W2170830743C1491633281 @default.
• W2170830743 hasConceptScore W2170830743C16224149 @default.
• W2170830743 hasConceptScore W2170830743C178790620 @default.
• W2170830743 hasConceptScore W2170830743C185592680 @default.
• W2170830743 hasConceptScore W2170830743C189165786 @default.
• W2170830743 hasConceptScore W2170830743C2776193487 @default.
• W2170830743 hasConceptScore W2170830743C2777107211 @default.
• W2170830743 hasConceptScore W2170830743C2777658100 @default.
• W2170830743 hasConceptScore W2170830743C2779814568 @default.
• W2170830743 hasConceptScore W2170830743C2780644872 @default.
• W2170830743 hasConceptScore W2170830743C502942594 @default.
• W2170830743 hasConceptScore W2170830743C55493867 @default.
• W2170830743 hasConceptScore W2170830743C84416704 @default.
• W2170830743 hasConceptScore W2170830743C85789140 @default.
• W2170830743 hasConceptScore W2170830743C86803240 @default.
• W2170830743 hasConceptScore W2170830743C95444343 @default.
• W2170830743 hasIssue "17" @default.
• W2170830743 hasLocation W21708307431 @default.
• W2170830743 hasOpenAccess W2170830743 @default.
• W2170830743 hasPrimaryLocation W21708307431 @default.
• W2170830743 hasRelatedWork W1963507641 @default.

• next